Clinical trial for novel minimally invasive synovial biopsy in rheumatic diseases
Not Applicable
Recruiting
- Conditions
- Rheumatic diseases
- Registration Number
- JPRN-UMIN000018076
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who dismissed as inadequate for medical reason by attending doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Examination for safety Early complication (30 minute after biopsy): Examine presence/absence of complication such as bleeding, neural symptom. Late complication(5~7 days after biopsy): Examine infection and complication of biopsy needle inserting portion . 2. Examination for tolerability: Evaluate pain, swelling, stiffness in 3 points; before biopsy, 30 minute after biopsy, 5-7 days after biopsy using by visual analog scale. 3. Examination for efficacy and reliability of tissue samples: Count and measuring the size of sample and perform general histological and biological examination. Surplus samples were cultured and analyzed gene and protein expression in our laboratory.
- Secondary Outcome Measures
Name Time Method